-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA: APPROVED OTC INTRANASAL NALOXONE PRODUCT, REXTOVY, A 4 MG NALOXONE HYDROCHLORIDE NASAL SPRAY FOR EMERGENCY TREATMENT OF OPIOID OVERDOSE

Reuters·06/16/2026 12:46:59

Please log in to view news